CASSIOPEA N overview

Cassiopea S.p.A. / Key word(s): Delisting Cassiopea SpA announces approval of delisting of its shares on SIX Swiss Exchange 25.02.2022 / 07:00 Lainate, Italy - February 25, 2022: Cassiopea S.p.A. (SIX: SKIN), ('Cassiopea'), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to address long-standing essential dermatological conditions, today announced that SIX Exchange Regulation has approved the delisting of its...

Cassiopea S.p.A. / Key word(s): Delisting Cassiopea announces filing for delisting of its registered shares from SIX Swiss Exchange 04-Feb-2022 / 07:01 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR Lainate, Italy, February 4, 2022: Cassiopea S.p.A. (SIX: SKIN) ('Cassiopea') today announced that it has filed for delisting of its registered shares from SIX Swiss...

Cassiopea S.p.A. / Key word(s): Miscellaneous Cassiopea SpA announces preparing delisting of shares on SIX Swiss Exchange 20.01.2022 / 07:00 Lainate, Italy - January 20, 2022: Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to address long-standing essential dermatological conditions, today announced that it has been asked by Cosmo, its almost 100% shareholder, to proceed to delist...

EQS-Ad-hoc: Cassiopea S.p.A. / Key word(s): Takeover COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A ANNOUNCE SETTLEMENT OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES IN CASSIOPEA S.P.A. 17-Dec-2021 / 07:01 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland and Lainate, Italy - 17 December 2021 - Cosmo Pharmaceuticals N.V. (SIX: COPN) ("Cosmo")...

EQS-Ad-hoc: Cassiopea S.p.A. / Key word(s): Takeover COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A. PUBLISH DEFINITIVE FINAL RESULTS OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES OF CASSIOPEA S.P.A. 07-Dec-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland and Lainate, Italy - 7 December 2021 - Cosmo Pharmaceuticals N.V. (SIX:...

EQS-Ad-hoc: Cassiopea S.p.A. / Key word(s): Takeover COSMO PHARMACEUTICALS N.V. and Cassiopea S.p.a. PUBLISH PROVISIONAL final RESULTS OF PUBLIC EXCHANGE OFFER FOR all publicly held shares of CASSIOPEA S.P.A. 03-Dec-2021 / 07:01 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland and Lainate, Italy - 3 December 2021 - Cosmo Pharmaceuticals N.V. (SIX:...

EQS Group-Ad-hoc: Cassiopea S.p.A. / Key word(s): Takeover COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A. PUBLISH DEFINITIVE INTERIM RESULTS OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES OF CASSIOPEA S.P.A. AND DECLARE THE OFFER SUCCESSFUL 18-Nov-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. About Cosmo Pharmaceuticals Cosmo is a specialty pharmaceutical company focused on developing...

EQS Group-Ad-hoc: Cassiopea S.p.A. / Key word(s): Takeover COSMO PHARMACEUTICALS N.V. AND CASSIOPEA S.P.A. PUBLISH PROVISIONAL INTERIM RESULTS OF PUBLIC EXCHANGE OFFER FOR ALL PUBLICLY HELD SHARES OF CASSIOPEA S.P.A. 16-Nov-2021 / 07:01 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland and Lainate, Italy - 16 November 2021 - Cosmo Pharmaceuticals N.V....